Related Experiment Videos
Pharmacist domiciliary visiting in England: identifying the characteristics associated with continuation
Debi Bhattacharya1, David J Wright, John R Purvis
1School of Chemical Sciences & Pharmacy, University of East Anglia, Norwich NR4 7TJ, UK. D.Bhattacharya@uea.ac.uk
Pharmacy World & Science : PWS
|November 22, 2007
Summary
Pharmacist Domiciliary Visiting Services (PDVSs) in England often terminated within a year due to low referrals. Operational PDVSs utilized more referral sources, like social services and GPs, indicating a link to service continuation.
Area of Science:
- Pharmacy Practice
- Healthcare Services Research
Background:
- Pharmacist Domiciliary Visiting Services (PDVSs) aim to extend pharmaceutical care to patients unable to visit pharmacies.
- Understanding the factors influencing the success and failure of these services is crucial for optimizing healthcare delivery.
Purpose of the Study:
- To characterize the operational and terminated Pharmacist Domiciliary Visiting Services (PDVSs) across England.
- To identify key differences and similarities between ongoing and discontinued PDVSs.
Main Methods:
- A national questionnaire survey was distributed to all Primary Care Organizations (PCOs) in England.
- Data collected included the number of PDVSs, their operational status, service characteristics, and reasons for termination.
- Statistical analysis identified factors associated with PDVS continuation or termination.
Main Results:
- A high response rate (81.5%) was achieved, with 70% of terminated PDVSs ceasing within one year, often due to insufficient referrals.
- While PDVS designs varied, operational services demonstrated a greater diversity of referral sources, particularly from social services, general medical practitioners, and community nurses.
Conclusions:
- No two PDVSs were identical, but common characteristics were observed.
- The number and type of referral sources, crucial for generating service demand, are strongly associated with the long-term continuation of PDVSs.
Related Concept Videos
01:29Documentation in Long-Term and Home Healthcare Setting
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
01:19Restorative Care
Restorative care is provided once a patient has been discharged from a healthcare facility and requires additional services. The additional services include home care, rehabilitation programs, and extended care. Restorative care centers help the patient regain their previous level of functioning or acquire a new level of functioning due to the incapacitating effects of a disease or a disability. It aims to assist patients in enhancing their quality of life by encouraging independence,...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:25Continuing Care
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...